Table 1.
Summary of suggested antenatal visit timing in setting of COVID-19 pandemic
| Gestational age | In-person OB visit | Ultrasound | Comments |
|---|---|---|---|
| <11 weeksa | Telephone OB intake | ||
| 11–13 weeksb | X | X (dating/NT) | Initial OB lab tests |
| 20 weeks | X | X (anatomy) | |
| 28 weeks | X | Labs/vaccines | |
| 32 weeks | X (if indicated) | Telehealth | |
| 36 weeks | X | X (if indicated) | GBS/HIV screen |
| 37 weeks to delivery | Weekly telehealth and kick counts | ||
| Postpartum | Telehealth |
Use of telehealth visits facilitate blood pressure cuff/kick counts at home so that in-person visits are not necessary. Additional visits including diabetes control, hypertension, mood disorder, etc may be done remotely with teleheath as well.
COVID-19, coronavirus 2019; GBS, group B strep; NT, nuchal translucency; OB, obstetric.
Boelig. MFM guidance for COVID-19. Am J Obstet Gynecol MFM 2020.
a
Earlier scan may be indicated if at risk for ectopic
b
If viability is previously established, consider skipping 11–13 week scan and offering cell-free DNA.